Office of Health Economics

The Office of Health Economics conducts research and provides consultancy services on health economics and related policy issues that affect health care and the life sciences industries.

Prochain(s) (0)

Désolé, il n'y a pas d'événements à venir

Dernier(s) (31)

Image principale de Supporting Sustainability in the Era of Green Pharmaceuticals

Supporting Sustainability in the Era of Green Pharmaceuticals

Wed, Jun 7, 3:00 PM GMT+1

Libre

Image principale de Cell & Gene Therapies: Can We Find Innovative Ways to Pay?

Cell & Gene Therapies: Can We Find Innovative Ways to Pay?

Wed, May 10, 8:45 AM

Libre

Image principale de Valuing Vaccines: The Economics of Vaccines & Immunisations

Valuing Vaccines: The Economics of Vaccines & Immunisations

Wed, Apr 26, 3:00 PM GMT+1

Libre

Image principale de Evaluating multiple myeloma therapies

Evaluating multiple myeloma therapies

Tue, Feb 28, 3:00 PM GMT

Libre

Image principale de The Value of Vaccines and Taskforces

The Value of Vaccines and Taskforces

Tue, Feb 7, 3:15 PM GMT

Libre

Image principale de OHE Innovation Policy Prize | Award Ceremony

OHE Innovation Policy Prize | Award Ceremony

Tue, Jan 24, 5:30 PM

Libre

Image principale de Insights from 2022 & Emerging Issues for 2023

Insights from 2022 & Emerging Issues for 2023

Wed, Dec 7, 3:00 PM GMT

Libre

Image principale de Vaccines, Antivirals, Lockdowns & COVID: Learnings from the Pandemic

Vaccines, Antivirals, Lockdowns & COVID: Learnings from the Pandemic

Thu, Oct 20, 3:00 PM GMT+1

Libre

Image principale de Universal Health Coverage: more than just old wine in a new bottle?

Universal Health Coverage: more than just old wine in a new bottle?

Thu, Oct 6, 6:00 PM GMT+1

Libre

Image principale de Can we “Netflix” the broken antibiotics market?

Can we “Netflix” the broken antibiotics market?

Thu, Sep 29, 2:30 PM GMT+1

Libre

Image principale de Health Technology Assessment of Gene Therapies: Are Methods Fit for Purpose

Health Technology Assessment of Gene Therapies: Are Methods Fit for Purpose

Wed, Sep 14, 3:00 PM GMT+1

Libre

Image principale de The Value of a QALY towards the End of Life and its Determinants

The Value of a QALY towards the End of Life and its Determinants

Tue, Jun 21, 12:30 PM GMT+1

Libre

Image principale de Supporting Sustainability in the Era of Green Pharmaceuticals

Supporting Sustainability in the Era of Green Pharmaceuticals

Wed, Jun 7, 3:00 PM GMT+1

Libre

Image principale de Cell & Gene Therapies: Can We Find Innovative Ways to Pay?

Cell & Gene Therapies: Can We Find Innovative Ways to Pay?

Wed, May 10, 8:45 AM

Libre

Image principale de Valuing Vaccines: The Economics of Vaccines & Immunisations

Valuing Vaccines: The Economics of Vaccines & Immunisations

Wed, Apr 26, 3:00 PM GMT+1

Libre

Image principale de Evaluating multiple myeloma therapies

Evaluating multiple myeloma therapies

Tue, Feb 28, 3:00 PM GMT

Libre

Image principale de The Value of Vaccines and Taskforces

The Value of Vaccines and Taskforces

Tue, Feb 7, 3:15 PM GMT

Libre

Image principale de OHE Innovation Policy Prize | Award Ceremony

OHE Innovation Policy Prize | Award Ceremony

Tue, Jan 24, 5:30 PM

Libre

Image principale de Insights from 2022 & Emerging Issues for 2023

Insights from 2022 & Emerging Issues for 2023

Wed, Dec 7, 3:00 PM GMT

Libre

Image principale de Vaccines, Antivirals, Lockdowns & COVID: Learnings from the Pandemic

Vaccines, Antivirals, Lockdowns & COVID: Learnings from the Pandemic

Thu, Oct 20, 3:00 PM GMT+1

Libre

Image principale de Universal Health Coverage: more than just old wine in a new bottle?

Universal Health Coverage: more than just old wine in a new bottle?

Thu, Oct 6, 6:00 PM GMT+1

Libre

Image principale de Can we “Netflix” the broken antibiotics market?

Can we “Netflix” the broken antibiotics market?

Thu, Sep 29, 2:30 PM GMT+1

Libre

Image principale de Health Technology Assessment of Gene Therapies: Are Methods Fit for Purpose

Health Technology Assessment of Gene Therapies: Are Methods Fit for Purpose

Wed, Sep 14, 3:00 PM GMT+1

Libre

Image principale de The Value of a QALY towards the End of Life and its Determinants

The Value of a QALY towards the End of Life and its Determinants

Tue, Jun 21, 12:30 PM GMT+1

Libre

The Office of Health Economics conducts research and provides consultancy services on health economics and related policy issues that affect health care and the life sciences industries.

Événements

Désolé, il n'y a pas d'événements à venir
Image principale de Supporting Sustainability in the Era of Green Pharmaceuticals

Supporting Sustainability in the Era of Green Pharmaceuticals

Wed, Jun 7, 3:00 PM GMT+1

Libre

Image principale de Cell & Gene Therapies: Can We Find Innovative Ways to Pay?

Cell & Gene Therapies: Can We Find Innovative Ways to Pay?

Wed, May 10, 8:45 AM

Libre

Image principale de Valuing Vaccines: The Economics of Vaccines & Immunisations

Valuing Vaccines: The Economics of Vaccines & Immunisations

Wed, Apr 26, 3:00 PM GMT+1

Libre

Image principale de Evaluating multiple myeloma therapies

Evaluating multiple myeloma therapies

Tue, Feb 28, 3:00 PM GMT

Libre

Image principale de The Value of Vaccines and Taskforces

The Value of Vaccines and Taskforces

Tue, Feb 7, 3:15 PM GMT

Libre

Image principale de OHE Innovation Policy Prize | Award Ceremony

OHE Innovation Policy Prize | Award Ceremony

Tue, Jan 24, 5:30 PM

Libre

Image principale de Insights from 2022 & Emerging Issues for 2023

Insights from 2022 & Emerging Issues for 2023

Wed, Dec 7, 3:00 PM GMT

Libre

Image principale de Vaccines, Antivirals, Lockdowns & COVID: Learnings from the Pandemic

Vaccines, Antivirals, Lockdowns & COVID: Learnings from the Pandemic

Thu, Oct 20, 3:00 PM GMT+1

Libre

Image principale de Universal Health Coverage: more than just old wine in a new bottle?

Universal Health Coverage: more than just old wine in a new bottle?

Thu, Oct 6, 6:00 PM GMT+1

Libre

Image principale de Can we “Netflix” the broken antibiotics market?

Can we “Netflix” the broken antibiotics market?

Thu, Sep 29, 2:30 PM GMT+1

Libre

Image principale de Health Technology Assessment of Gene Therapies: Are Methods Fit for Purpose

Health Technology Assessment of Gene Therapies: Are Methods Fit for Purpose

Wed, Sep 14, 3:00 PM GMT+1

Libre

Image principale de The Value of a QALY towards the End of Life and its Determinants

The Value of a QALY towards the End of Life and its Determinants

Tue, Jun 21, 12:30 PM GMT+1

Libre

Image principale de Supporting Sustainability in the Era of Green Pharmaceuticals

Supporting Sustainability in the Era of Green Pharmaceuticals

Wed, Jun 7, 3:00 PM GMT+1

Libre

Image principale de Cell & Gene Therapies: Can We Find Innovative Ways to Pay?

Cell & Gene Therapies: Can We Find Innovative Ways to Pay?

Wed, May 10, 8:45 AM

Libre

Image principale de Valuing Vaccines: The Economics of Vaccines & Immunisations

Valuing Vaccines: The Economics of Vaccines & Immunisations

Wed, Apr 26, 3:00 PM GMT+1

Libre

Image principale de Evaluating multiple myeloma therapies

Evaluating multiple myeloma therapies

Tue, Feb 28, 3:00 PM GMT

Libre

Image principale de The Value of Vaccines and Taskforces

The Value of Vaccines and Taskforces

Tue, Feb 7, 3:15 PM GMT

Libre

Image principale de OHE Innovation Policy Prize | Award Ceremony

OHE Innovation Policy Prize | Award Ceremony

Tue, Jan 24, 5:30 PM

Libre

Image principale de Insights from 2022 & Emerging Issues for 2023

Insights from 2022 & Emerging Issues for 2023

Wed, Dec 7, 3:00 PM GMT

Libre

Image principale de Vaccines, Antivirals, Lockdowns & COVID: Learnings from the Pandemic

Vaccines, Antivirals, Lockdowns & COVID: Learnings from the Pandemic

Thu, Oct 20, 3:00 PM GMT+1

Libre

Image principale de Universal Health Coverage: more than just old wine in a new bottle?

Universal Health Coverage: more than just old wine in a new bottle?

Thu, Oct 6, 6:00 PM GMT+1

Libre

Image principale de Can we “Netflix” the broken antibiotics market?

Can we “Netflix” the broken antibiotics market?

Thu, Sep 29, 2:30 PM GMT+1

Libre

Image principale de Health Technology Assessment of Gene Therapies: Are Methods Fit for Purpose

Health Technology Assessment of Gene Therapies: Are Methods Fit for Purpose

Wed, Sep 14, 3:00 PM GMT+1

Libre

Image principale de The Value of a QALY towards the End of Life and its Determinants

The Value of a QALY towards the End of Life and its Determinants

Tue, Jun 21, 12:30 PM GMT+1

Libre